University of Texas's MD Anderson Cancer: Antihistamines Can Influence Immunotherapy Response by Enhancing T Cell Activation
November 25, 2021
November 25, 2021
HOUSTON, Texas, Nov. 25 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Nov. 24, 2021:
* * *
Study uncovers new role for histamine receptor, suggesting possible treatment approach in combination with checkpoint inhibitors
* * *
New research from The University of Texas MD Anderson Cancer Center found that treatment with antihistamines, a commonly used allergy medication, was associated w . . .
* * *
Study uncovers new role for histamine receptor, suggesting possible treatment approach in combination with checkpoint inhibitors
* * *
New research from The University of Texas MD Anderson Cancer Center found that treatment with antihistamines, a commonly used allergy medication, was associated w . . .